1. Richter GM, Coleman AL. Minimally invasive glaucoma surgery: current status and future prospects. Clin Ophthalmol 2016;10:189–206.

2. Post M, Lubinski W, Sliwiak D, Podborączyńska-Jodko K, Mularczyk M. XEN Gel Stent in the management of primary open-angle glaucoma. Doc Ophthalmol 2020;141:65–76.

3. Lewis RA. Ab interno approach to the subconjunctival space using a collagen glaucoma stent. J Cataract Refract Surg 2014;40:1301–1306.

4. Sheybani A, Reitsamer H, Ahmed, II. Fluid dynamics of a novel micro-fistula implant for the surgical treatment of glaucoma. Invest Ophthalmol Vis Sci 2015;56:4789–4795.

5. Schlenker MB, Gulamhusein H, Conrad-Hengerer I, Somers A, Lenzhofer M, Stalmans I, et al. Efficacy, safety, and risk factors for failure of standalone ab interno gelatin microstent implantation versus standalone trabeculectomy. Ophthalmology 2017;124:1579–1588.

6. Marcos Parra MT, Salinas Lopez JA, Lopez Grau NS, María Ceausescu A, José Pérez Santonja J. XEN implant device versus trabeculectomy, either alone or in combination with phacoemulsification, in open-angle glaucoma patients. Graefes Arch Clin Exp Ophthalmol 2019;257:1741–1750.

7. Sharpe R, Pham G, Chang P. Comparison of ab interno XEN gelatin stent vs trabeculectomy with mitomycin C: A retrospective study. J Curr Glaucoma Pract 2020;14:87– 92.

8. Grover DS, Flynn WJ, Bashford KP, Lewis RA, Duh Y-J, Nangia RS, et al. Performance and safety of a new ab interno gelatin stent in refractory glaucoma at 12 months. Am J Ophthalmol 2017;183:25–36.

9. Galal A, Bilgic A, Eltanamly R, Osman A. XEN glaucoma implant with mitomycin C 1-year follow-up: Result and complications. J Ophthalmol 2017;2017:5457246.

10. Arnould L, Theillac V, Moran S, Gatinel D, Grise-Dulac A. Recurrent exposure of XEN gel stent implant and conjunctival erosion. J Glaucoma 2019;28:e37-e40.

11. Olgun A, Imamoglu S, Karapapak M, Düzgün E, Kaçar H. Endophthalmitis after XEN gel stent implantation: 2 cases. J Glaucoma 2018;27:e191-e4.

12. Buffault J, Baudouin C, Labbe A. Is the Xen(R) gel stent really minimally invasive? Am J Ophthalmol Case Rep 2020;19:100850.

13. Kennedy A, Haddad F, Georgopoulos M. Aqueous misdirection syndrome following ab interno gelatin stent can be managed successfully with anterior vitrectomy approach. Eur J Ophthalmol 2021;31:16–19.

14. Gillmann K, Bravetti GE, Mansouri K. Delayed obstruction of XEN gel stent by cell debris in primary openangle glaucoma: A new insight into the pathophysiology of filtration device failure. J Curr Glaucoma Pract 2019;13:113–115.

15. Gillmann K, Mansouri K, Bravetti GE, Mermoud A. Chronic intraocular inflammation as a risk factor for XEN gel stent occlusion: A case of microscopic examination of a fibrinobstructed XEN stent. J Glaucoma 2018;27:739–741.

16. Tadrosse AF, Khouri AS. Laser iridoplasty to treat irisoccluded XEN gel stent. J Glaucoma 2020;29:e91-e2.

17. Midha N, Gillmann K, Chaudhary A, et al. Efficacy of needling revision after XEN gel stent implantation: A prospective study. J Glaucoma 2020;29:11–14.

18. Karimi A, Lindfield D, Turnbull A, Dimitriou C, Bhatia B, Radwan M, et al. A multi-centre interventional case series of 259 ab-interno Xen gel implants for glaucoma, with and without combined cataract surgery. Eye (Lond) 2019;33:469–477.

19. Eagle RC Jr., Razeghinejad R. Xen gel stent occlusion with iris pigment epithelium. Clin Exp Ophthalmol 2020;48:258–259.

20. Scantling-Birch Y, Merzougui W, Lindfield D. Early postoperative lumen blockage of ab-interno gel stent (XEN) cleared with Nd:YAG laser. Indian J Ophthalmol 2020;68:524.

21. Sng CCA, Chew PTK, Htoon HM, et al. Case series of combined XEN implantation and phacoemulsification in Chinese eyes: One-year outcomes. Adv Ther 2019;36:3519–3529.

22. Karri B, Gupta C, Mathews D. Endophthalmitis following XEN stent exposure. J Glaucoma 2018;27:931–933.